Trial Profile
A single dose, open-label, crossover study evaluating pharmacokinetics and bioequivalence in fasted state of heat-stressed and non-heat-stressed Dapagliflozin tablets in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 May 2017
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- 26 Oct 2015 New trial record